Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29


Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.

Chow EPF, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Regan DG, Hocking JS, Garland SM, Cornall AM, Atchison S, Bradshaw CS, McNulty A, Owen L, Marshall L, Russell DB, Kaldor JM, Chen MY.

Vaccine. 2019 Oct 31;37(46):6907-6914. doi: 10.1016/j.vaccine.2019.09.052. Epub 2019 Sep 24.


Analysis of Infection Loads in Mycoplasma genitalium Clinical Specimens by Use of a Commercial Diagnostic Test.

Murray GL, Danielewski J, Bodiyabadu K, Machalek DA, Bradshaw CS, Costa AM, Birnie J, Garland SM.

J Clin Microbiol. 2019 Aug 26;57(9). pii: e00344-19. doi: 10.1128/JCM.00344-19. Print 2019 Sep.


The impact of sample storage on molecular-based detection of Mycoplasma genitalium.

Murray GL, Su JP, Birnie J, Danielewski J, Machalek DA, Bradshaw CS, Read TRH, Costa AM, Garland SM.

J Appl Microbiol. 2019 Oct;127(4):1219-1223. doi: 10.1111/jam.14359. Epub 2019 Jul 2.


Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program.

Machalek DA, Roberts JM, Garland SM, Thurloe J, Richards A, Chambers I, Sivertsen T, Farnsworth A.

Med J Aust. 2019 Aug;211(3):113-119. doi: 10.5694/mja2.50223. Epub 2019 Jun 5.


Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact.

Brotherton JM, Hawkes D, Sultana F, Malloy MJ, Machalek DA, Smith MA, Garland SM, Saville M.

Vaccine. 2019 Jan 14;37(3):412-416. doi: 10.1016/j.vaccine.2018.11.075. Epub 2018 Dec 11.


Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination.

Machalek DA, Garland SM, Brotherton JML, Bateson D, McNamee K, Stewart M, Rachel Skinner S, Liu B, Cornall AM, Kaldor JM, Tabrizi SN.

J Infect Dis. 2018 Apr 23;217(10):1590-1600. doi: 10.1093/infdis/jiy075.


HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.

Cornall AM, Poljak M, Garland SM, Phillips S, Machalek DA, Tan JH, Quinn MA, Tabrizi SN.

Papillomavirus Res. 2017 Dec;4:79-84. doi: 10.1016/j.pvr.2017.10.002. Epub 2017 Oct 18.


Using Facebook to Recruit Young Australian Men Into a Cross-Sectional Human Papillomavirus Study.

Das R, Machalek DA, Molesworth EG, Garland SM.

J Med Internet Res. 2017 Nov 17;19(11):e389. doi: 10.2196/jmir.8739.


Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men.

Machalek DA, Jin F, Poynten IM, Hillman RJ, Templeton DJ, Law C, Roberts JM, Tabrizi SN, Garland SM, Farnsworth A, Fairley CK, Grulich AE; SPANC study team.

Papillomavirus Res. 2016 Dec;2:97-105. doi: 10.1016/j.pvr.2016.05.003. Epub 2016 May 24.


Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men.

Poynten IM, Tabrizi SN, Jin F, Templeton DJ, Machalek DA, Cornall A, Phillips S, Fairley CK, Garland SM, Law C, Carr A, Hillman RJ, Grulich AE; SPANC Study Team.

Papillomavirus Res. 2017 Jun;3:80-84. doi: 10.1016/j.pvr.2017.02.003. Epub 2017 Feb 21.


Reducing the burden of sexually transmissible infections in Papua New Guinea requires strengthening of clinical services and engaging men.

Hocking JS, Vaughan C, Lau A, Machalek DA, Graham S.

Sex Health. 2016 Oct;13(5):401-403. doi: 10.1071/SH16058.


Maximizing the Impact of Human Papillomavirus Vaccination.

Garland SM, Machalek DA.

Clin Infect Dis. 2017 Sep 15;65(6):890-892. doi: 10.1093/cid/cix459. No abstract available.


The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.

Jin F, Roberts JM, Grulich AE, Poynten IM, Machalek DA, Cornall A, Phillips S, Ekman D, McDonald RL, Hillman RJ, Templeton DJ, Farnsworth A, Garland SM, Fairley CK, Tabrizi SN; SPANC Research Team.

AIDS. 2017 Jun 1;31(9):1303-1311. doi: 10.1097/QAD.0000000000001462.


Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study.

Machalek DA, Wark JD, Tabrizi SN, Hopper JL, Bui M, Dite GS, Cornall AM, Pitts M, Gertig D, Erbas B, Garland SM.

Twin Res Hum Genet. 2017 Feb;20(1):10-18. doi: 10.1017/thg.2016.93. Epub 2016 Dec 5.


Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.

Cornall AM, Poljak M, Garland SM, Phillips S, Tan JH, Machalek DA, Quinn MA, Tabrizi SN.

Eur J Clin Microbiol Infect Dis. 2017 Mar;36(3):545-551. doi: 10.1007/s10096-016-2831-5. Epub 2016 Nov 8.


Human Papillomavirus Prevalence in Unvaccinated Heterosexual Men After a National Female Vaccination Program.

Machalek DA, Chow EP, Garland SM, Wigan R, Cornall AM, Fairley CK, Kaldor JM, Hocking JS, Williams H, McNulty A, Bell C, Marshall L, Ooi C, Chen MY, Tabrizi SN.

J Infect Dis. 2017 Jan 15;215(2):202-208. doi: 10.1093/infdis/jiw530.


Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia.

Tung IL, Machalek DA, Garland SM.

PLoS One. 2016 Aug 26;11(8):e0161846. doi: 10.1371/journal.pone.0161846. eCollection 2016.


CpG Methylation Analysis of HPV16 in Laser Capture Microdissected Archival Tissue and Whole Tissue Sections from High Grade Anal Squamous Intraepithelial Lesions: A Potential Disease Biomarker.

Molano M, Tabrizi SN, Garland SM, Roberts JM, Machalek DA, Phillips S, Chandler D, Hillman RJ, Grulich AE, Jin F, Poynten IM, Templeton DJ, Cornall AM; SPANC Study Team.

PLoS One. 2016 Aug 16;11(8):e0160673. doi: 10.1371/journal.pone.0160673. eCollection 2016.


Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.

Chow EPF, Machalek DA, Tabrizi SN, Danielewski JA, Fehler G, Bradshaw CS, Garland SM, Chen MY, Fairley CK.

Lancet Infect Dis. 2017 Jan;17(1):68-77. doi: 10.1016/S1473-3099(16)30116-5. Epub 2016 Jun 6. Erratum in: Lancet Infect Dis. 2017 Jan;17 (1):17.


A Composite Cytology-Histology Endpoint Allows a More Accurate Estimate of Anal High-Grade Squamous Intraepithelial Lesion Prevalence.

Machalek DA, Poynten IM, Jin F, Hillman RJ, Templeton DJ, Law C, Roberts JM, Tabrizi SN, Garland SM, Farnsworth A, Fairley CK, Grulich AE; SPANC study team.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1134-43. doi: 10.1158/1055-9965.EPI-15-1106. Epub 2016 Apr 27.


Comparison of the Roche CobasĀ® 4800 HPV assay to Roche Amplicor for detection of high-risk human papillomavirus.

Phillips S, Cornall AM, Machalek DA, Garland SM, Bateson D, Garefalakis M, Tabrizi SN.

Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1305-7. doi: 10.1007/s10096-016-2665-1. Epub 2016 May 13.


EUROarray human papillomavirus (HPV) assay is highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.

Cornall AM, Poljak M, Garland SM, Phillips S, Machalek DA, Tan JH, Quinn MA, Tabrizi SN.

Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):1033-6. doi: 10.1007/s10096-016-2634-8. Epub 2016 Apr 5.


Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions.

Cornall AM, Roberts JM, Molano M, Machalek DA, Phillips S, Hillman RJ, Grulich AE, Jin F, Poynten IM, Templeton DJ, Garland SM, Tabrizi SN; SPANC Study Team.

BMJ Open. 2015 Aug 26;5(8):e008439. doi: 10.1136/bmjopen-2015-008439.


How to best measure the effectiveness of male human papillomavirus vaccine programmes?

Garland SM, Molesworth EG, Machalek DA, Cornall AM, Tabrizi SN.

Clin Microbiol Infect. 2015 Sep;21(9):834-41. doi: 10.1016/j.cmi.2015.05.038. Epub 2015 Jun 5. Review.


The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study.

Machalek DA, Grulich AE, Hillman RJ, Jin F, Templeton DJ, Tabrizi SN, Garland SM, Prestage G, McCaffery K, Howard K, Tong W, Fairley CK, Roberts J, Farnsworth A, Poynten IM; SPANC Study Team.

BMC Public Health. 2013 Oct 9;13:946. doi: 10.1186/1471-2458-13-946.


The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men.

Machalek DA, Grulich AE, Jin F, Templeton DJ, Poynten IM.

Sex Health. 2012 Dec;9(6):527-37. doi: 10.1071/SH12043. Review.


The epidemiology of anal cancer.

Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ.

Sex Health. 2012 Dec;9(6):504-8. doi: 10.1071/SH12070.


Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.

Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, Templeton DJ, Grulich AE.

Lancet Oncol. 2012 May;13(5):487-500. doi: 10.1016/S1470-2045(12)70080-3. Epub 2012 Mar 23. Review.


Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer.

O'Toole SA, Machalek DA, Shearer RF, Millar EK, Nair R, Schofield P, McLeod D, Cooper CL, McNeil CM, McFarland A, Nguyen A, Ormandy CJ, Qiu MR, Rabinovich B, Martelotto LG, Vu D, Hannigan GE, Musgrove EA, Christ D, Sutherland RL, Watkins DN, Swarbrick A.

Cancer Res. 2011 Jun 1;71(11):4002-14. doi: 10.1158/0008-5472.CAN-10-3738.

Supplemental Content

Loading ...
Support Center